Because of its role in cellular energy, NAD+ IV therapy has been explored for benefits such as improved cognitive function, reduced fatigue, and potential anti-aging effects
Patients who are already managing the once-weekly injection cadence of Semaglutide or Tirzepatide and do not want to add daily injections are not good candidates for GHK-Cu, not because of any contraindication, but because they wont maintain the protocol consistently enough to see results
NAD+/NADH Moves Electrons The NAD+/NADH pair is central to glycolysis, the citric-acid cycle, and mitochondrial energy metabolism
To an extent, yes
All of these conditions get worse with the progression of kidney disease and the impairment of kidney function, thus stimulating RBC death and creating a vicious circle
You may wonder, if my body produces glutathione naturally, why would I need an injection